Want to join the conversation?
Pharma company $AGN said it received approval from the U.S. Food and Drug Administration (FDA) to market JUVEDERM VOLBELLA XC for use in lips and Perioral Rhytid. The injectable gel is used for lip augmentation and to soften the appearance of lines around the mouth through one year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?